Increased in vitro interleukin-12 production by peripheral blood in high-risk IDDM first degree relatives

Hormone and Metabolic Research

Volumn 29, Issue 4, 1997, Pages 168-171

  Szelachowska, M ^a   Kretowski, A ^a   Kinalska, I ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Interleukin 12; Pathogenesis; Type 1 Diabetes Mellitus

Indexed keywords

ADOLESCENT; ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEOMETRY; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RELATIVE;

EID: 0030962503     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979014     Document Type: Article

References (27)

1. Adorini L, Magram J, Trembleau S: The role of endogenous IL-12 in the induction of Th1-cell-mediated autoimmune disease. Res Immunol 146: 645-649 (1995).
2. Botazzo GF, Dean BM, Mc Nally GM, McKay EH, Swift PGF, Gamble DR: In situ characterisation of autoimmune phenomena in the pancreatic insulitis. N Engl J Med 353: 360-363 (1985).
3. Cvallo MG, Pozzilli P, Bird C, Wadhwa M, Meager A, Visalli N, Gearing AJH, Andreani D, Thhorpe R: Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin Exp Immunol 86: 256-259 (1991).
4. Ciampolillo A, Guastamacchia E, Caragíulo L, Lollino G, De Robertis O, Lattanzi V, Giorgino R: In vitro secretion of interleukin-1β and interferon-γ by perihperal blood lymphomononuclear cells in diabetic patients. Diab Res Clin Pract 21: 87-93 (1993).
5. Dunger A, Cunningham JM, Delaney CA, Lowe JE, Green MHL, Bone AJ, Green IC: Tumor necrosis factor-α and interferonγ inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Diabetes 45: 183-189 (1996).
6. Henke A, Mohr C, Sprenger H, craebner C, Stelzner A, Nain M, Gemsa D: Coxsackievirus B3-inducted production of tumor necrosis factor-α, IL-Iβ, and IL-6 in human monocytes. J Immunol 148: 2270-2277 (1992).
7. Huang X, Yan J, Goddard A, Foulis A, James RFL, Lernmark A, Pujol-Borörell R, Rabinovitch A, Somoza N, Stewart TA: Interferon expression in the pancreases of patients with type 1 dibetes. Diabetes 44: 658-664 (1995).
8. Hussain MJ, Peakman M, Gallati H, Lo SSS, Hawa M, Vibertii GC, Watkins PJ, Leslie RD, Vergani D: Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39: 60-69 (1996).
9. Jiang Z, Woda BA: Cytokine gene expression in the islets of the diabetic Biobreeding/Worcester rats. J Immunol 146: 2990-2994 (1991).
10. Kinalska I, Kretowski A, Szelachowska M, Kowalska I, Peczynska J, Bingley P, Gale EAM: The estimation of the presence of islet cell antibodies in the first-degree relatives of insulin-dependent diabetes diabetes mellitus patients. Diabetologia Polska 2: 187-200 (1995).
11. Lee KU, Amano K, Yoon JW: Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 37: 8989-991 (1988).
12. Luger A, Schernthaner G, Urbanski A, Lunger TA: Cytokine production in patients with newly diagnosed diabetes mellitus. Eur J Clin Invest 18: 233-236 (1988).
13. McHugh S, Deighton J, Tifkin I, Ewan P: Kinetics and functional implications of Th1 and Th2 cytokine production following activation of peripheral blood mononuclear cells in primary culture. Eur J Immunol 26: 1260-1265 (1996).
14. Mosman TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17: 138-146 (1996).
15. Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI, Cuartero BG, Karlsen AE, Bjerre U, Lorenzen T: On the pathogenesis of IDDM. Diabetologia 37 (Suppl 2): S82-S89 (1994).
16. Morohoshi M, Fijisawa K, Uchimura I, Numano F: Glucose-dependent interleukin-6 and tumor necrosis factor production by peripheral blood monocytes in vitro. Diabetes 45: 954-959 (1996).
17. Ohno Y, Aoki N, Nishimura A: In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-α in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77: 1072-1077 (1993).
18. Oldstone MBA: Infectious agents as etiologic triggers of autoimmune disease. Curr Top Microbiol Immunol 145: 1-3 (1989).
19. O'Reilly LA, Hutchings PR, Crocker PR: Characterisation of pancreatic islet cell infiltrates in NOD mice: effecct of cell transfer and transgene expression. Eur J Immunol 21: 1171-1180 (1991).
20. Pociot F, Laurenc L, Jongeneel CV, MolvigJ, Wrsaae H, Abbal M, Thomsen M, Nerup J, Cambon-Thomsen A: Association of tumor necrosis factor and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin dependent diabetes mellitus. EurJ Immunol 23: 224-231 (1993).
21. Rabinovitch A: Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes 43: 613-621 (1994).
22. Rabinovitch A, Suarez-Pinzon WL, Shi Y, Morgan AR, Bleackley RC: DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction. Diabetologia 37: 733-738 (1994).
23. Rothe H, Vurkart V, Faust A, Kolb H: Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice. Diabetologia 39: 119-122 (1996).
24. Santamaria P, Gehrtz RC, Bryan MK, Barbosa JJ: Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretion by human monocytes: quantitative differences at the polymorphic levels. J Immunol 143: 913-922 (1989).
25. Scott P: II-12 initiation cytokine for cell-mediated immunity. Science 260: 496-497 (1993).
26. Trembleau S, Penna G, Bosi E, Mortara A, Gatley MK, Adorini L: Interleukin 12 administration induces T helper type I cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181: 817-821 (1995).
27. Yang XD, Tisch R, Singer SM, Cao ZA, Liblau RS, Schreiber RD, Mc Devitt HO: Effect of tumor necrosis factor-α on insulin-dependent diabetes mellitus. The early development of autoimmunity and the diabetogenic process. J Exp Med 180: 995-1004 (1994)